Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Valeant Pharmaceuticals International Inc (NYSE:VRX)

26.28
Delayed Data
As of 4:02pm ET
 +0.39 / +1.51%
Today’s Change
18.55
Today|||52-Week Range
206.51
-74.15%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
AssetsCash916.1M600.3M322.6M597.3M
 
 
 
 
 
Short Term Investment Cash752.0M-315.8M-277.7M279.9M
 
 
 
 
 
Cash & Short Term Investments920.5M600.3M322.6M613.3M
 
 
 
 
 
 
ReceivablesReceivables913.8M1.8B2.1B2.7B
 
 
 
 
 
 
InventoriesInventories531.3M883.0M950.6M1.3B
 
 
 
 
 
 
Current AssetsPrepaid Expenses------20.0M
 
 
Other Current Assets411.9M587.8M844.1M930.4M
 
 
 
 
 
Current Assets2.8B3.9B4.2B5.5B
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross636.2M2.1B2.3B2.6B
 
 
 
 
 
Depreciation-173.5M-838.8M-977.9M-1.2B
 
 
 
 
 
Intangible Assets14.5B22.6B20.6B41.6B
 
 
 
 
 
Other Assets14.6B22.8B20.8B41.9B
 
 
 
 
 
Total Assets18.0B28.0B26.4B49.0B
 
 
 
 
 
 
LiabilitiesAccounts Payable227.4M364.6M398.0M433.7M
 
 
 
 
 
Short Term Debt480.2M216.8M7.1M838.5M
 
 
 
 
 
Accrued Expenses164.3M227.4M258.7M692.1M
 
 
 
 
 
Other Current Liabilities1.0B1.6B2.0B3.6B
 
 
 
 
 
Other Liabilities1.8B2.5B2.7B5.3B
 
 
 
 
 
 
Total LiabilitiesLong Term Debt10.5B17.2B15.3B30.3B
 
 
 
 
 
Deferred Taxes-1.2B-2.3B-2.2B-5.7B
 
 
 
 
 
Other Liabilities590.3M570.9M466.7M1.1B
 
 
 
 
 
Total Liabilities14.2B22.7B20.9B42.9B
 
 
 
 
 
 
EquityMinority Interest0.00-2.5M-1.3M-3.9M
 
 
 
 
Preferred Stock0.000.000.000.00--
Common Equity3.7B5.1B5.3B5.9B
 
 
 
 
 
Total Shareholder Equity3.7B5.1B5.3B5.9B
 
 
 
 
 
 
Share InformationCommon Shares Outstanding303.9M333.0M334.4M342.9M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.